2024
Experiences of Stigma and Discrimination Compounded by Intersecting Identities among Individuals Receiving Medication for Opioid Use Disorder.
Nwanaji-Enwerem U, Redeker N, O'Connell M, Barry D, Iheanacho T, Knobf T, Scheinost D, Wang K, Yaggi K, Sadler L. Experiences of Stigma and Discrimination Compounded by Intersecting Identities among Individuals Receiving Medication for Opioid Use Disorder. Journal Of Health Care For The Poor And Underserved 2024, 35: 94-115. PMID: 38661862, DOI: 10.1353/hpu.2024.a919810.Peer-Reviewed Original ResearchOpioid use disorderExperiences of stigmaIndividuals experience stigmaMarginalized social positionsIdentity of peopleUse disorderIntersectional identitiesMarginalized identitiesSupport interventionsSocial positionQualitative findingsStigmaNegative experiencesNortheast United StatesUnited StatesImprove outcomesIdentityTreatment centersMOUDIndividual vulnerabilityMedicationPeopleDiscriminationIndividuals
2023
A National Study of Homelessness, Social Determinants of Health, and Treatment Engagement Among Outpatient Medication for Opioid Use Disorder-Seeking Individuals in the United States
Gazzola M, Carmichael I, Christian N, Zheng X, Madden L, Barry D. A National Study of Homelessness, Social Determinants of Health, and Treatment Engagement Among Outpatient Medication for Opioid Use Disorder-Seeking Individuals in the United States. Substance Abuse 2023, 44: 62-72. PMID: 37226909, DOI: 10.1177/08897077231167291.Peer-Reviewed Original ResearchConceptsOpioid use disorderUse disordersClinical characteristicsTreatment completionTreatment engagementTreatment Episodes Dataset-DischargesSocial determinantsLogistic regression modelsImportant social determinantOutpatient medicationsTreatment discontinuationIndependent predictorsCare treatmentTreatment episodesTreatment enrollmentMedical conditionsSDoH variablesHealth outcomesTreatment lengthGreater social vulnerabilityTreatment entryMOUDVulnerable populationsPoor engagementMedications